Akoya Biosciences Names BostonGene as a Qualified CRO Service Provider [Yahoo! Finance]
Akoya BioSciences, Inc. (AKYA)
Company Research
Source: Yahoo! Finance
WALTHAM, Mass., March 19, 2024 BUSINESS WIRE BostonGene , a leading provider of AI-driven molecular and immune profiling solutions, announced today that it has been named as a qualified contract research organization (CRO) of Akoya Biosciences (Nasdaq: AKYA; "Akoya"). By combining Akoya's single-cell imaging solutions with BostonGene's unparalleled expertise in spatial proteomics sample processing and analysis, researchers will gain unprecedented access to the intricate landscape of cellular biology, paving the way for groundbreaking discoveries and highly effective therapeutic strategies. Akoya offers a comprehensive suite of high-throughput automated multiplex immunofluorescence platforms, reagents, and ready-to-use PhenoCode™ panels. Akoya's PhenoCycler ® -Fusion and PhenoImager ® HT platforms are at the forefront of spatial biology and offer significant advancements in speed and scale for high-parameter tissue analysis. As a qualified CRO of Akoya, BostonGene will perform mul
Show less
Read more
Impact Snapshot
Event Time:
AKYA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AKYA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AKYA alerts
High impacting Akoya BioSciences, Inc. news events
Weekly update
A roundup of the hottest topics
AKYA
News
- Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024GlobeNewswire
- Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale [Yahoo! Finance]Yahoo! Finance
- Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and ScaleGlobeNewswire
- Akoya Biosciences Names BostonGene as a Qualified CRO Service ProviderBusiness Wire
- Akoya Biosciences, Inc. (NASDAQ: AKYA) had its price target lowered by analysts at JPMorgan Chase & Co. from $12.00 to $10.00. They now have an "overweight" rating on the stock.MarketBeat
AKYA
Earnings
- 3/4/24 - Beat
AKYA
Sec Filings
- 4/23/24 - Form ARS
- 4/23/24 - Form DEFA14A
- 4/23/24 - Form DEF
- AKYA's page on the SEC website